Craig-Hallum Reaffirms Their Buy Rating on Schrodinger (SDGR)
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Schrodinger (SDGR – Research Report). The company’s shares ...
Strong week for Schrödinger (NASDAQ:SDGR) shareholders doesn't alleviate pain of five-year loss
It is doubtless a positive to see that the Schrödinger, Inc. ( NASDAQ:SDGR ) share price has gained some 41% in ...
Schrödinger (SDGR): Revolutionizing Biopharma with Quantum Mechanics and AI
We recently published a list of 10 AI News And Ratings on Wall Street’s Radar. In this article, we are going to take a look ...
AI Pharma: 2 Paths to AI-Powered Drug Investment
Detailed price information for Schrodinger Inc (SDGR-Q) from The Globe and Mail including charting and trades.
Leerink Partnrs Expects Reduced Earnings for Schrödinger
Equities research analysts at Leerink Partnrs decreased their FY2024 EPS estimates for shares of Schrödinger in a research note issued on Wednesday, January 22nd. Leerink Partnrs analyst M. Foroohar ...
Schrödinger, Inc. (SDGR): Quantum Mechanics Meets AI in Biopharma, Backed by Hunterbrook’s ‘Key AI Winner’ Endorsement
We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...
KeyBanc raises Schrodinger stock target to $27, maintains Overweight
KeyBanc Capital Markets updated its outlook on Schrodinger (NASDAQ:SDGR), increasing the price target from $25.00 to $27.00 ...
Why Schrödinger, Inc. (SDGR) Is Skyrocketing Now
We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look at where Schrödinger, Inc. (NASDAQ:SDGR) stands against the other stocks ...
Insider Monkey14d
Top 10 Medical AI Stocks on Wall Street’s Radar
Relay Therapeutics Inc. (NASDAQ:RLAY) is a leading clinical-stage precision medicines firm focused on cancer treatments. The company uses AI and ML for drug discovery, combining computational ...